Lindsay-Miller A C
Clin Allergy. 1979 May;9(3):271-5. doi: 10.1111/j.1365-2222.1979.tb01553.x.
A double-blind group comparative trial comparing Opticrom with a matching placebo, over a four-week period, in seasonal allergic conjunctivitis is reported. Overall assessment of treatment benefit made at the end of the trial by the patients and the clinician showed a statistically significant difference in favour of Opticrom. Of the patients on Opticrom, eighteen (90%) said they improved while in the clinicians opinion, seventeen (85%) improved. Six patients using Opticrom and five using placebo complained of stinging of the eyes, while one patient using placebo complained of his eyes becoming bloodshot and watering.
据报道，一项双盲组对比试验在季节性过敏性结膜炎患者中进行，为期四周，比较了色甘酸钠与匹配的安慰剂。试验结束时患者和临床医生对治疗效果的总体评估显示，色甘酸钠组具有统计学上的显著优势。使用色甘酸钠的患者中，18人（90%）表示病情有所改善，而临床医生认为有17人（85%）病情改善。6名使用色甘酸钠的患者和5名使用安慰剂的患者抱怨眼睛有刺痛感，而1名使用安慰剂的患者抱怨眼睛充血和流泪。
